Patrick Borentain

Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial

Valérie Vilgrain, Héléna Pereira, Eric Assenat et al. · The Lancet Oncology · 2017 · 826 citations

Medicine, Oncology, Radiation Oncology +16

Pig Liver Sausage as a Source of Hepatitis E Virus Transmission to Humans

Philippe Colson, Patrick Borentain, Benjamin Queyriaux et al. · The Journal of Infectious Diseases · 2010 · 651 citations

Life Sciences, Infectious Diseases, Hepatology +14

Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: A randomized controlled trial

Jean Marc Perarnau, Amélie Le Gouge, Charlotte Nicolas et al. · Journal of Hepatology · 2014 · 195 citations

Medicine, Surgery, Hepatology +10

The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt

Christophe Bureau, Dominique Thabut, Caroline Jézequel et al. · Annals of Internal Medicine · 2021 · 183 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Treatment of severe acute hepatitis E by ribavirin

René Gerolami, Patrick Borentain, F. Raissouni et al. · Journal of Clinical Virology · 2011 · 146 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +12